ACON Investments and Humus Capital acquisition of Biosidus


Beccar Varela, M. & M. Bomchil and Rosso Alba, Francia & Asociados advised on the deal

ACON Investments in partnership with Humus Capital Partners, a private equity firm based in Argentina, have acquired a majority equity interest in Biosidus S.A. and Biosidus Farma S.A., Argentina’s largest manufacturer and distributor of biosimilar pharmaceuticals with exports worldwide to more than 25 countries across four continents.

ACON and HCP will continue Biosidus’ international expansion strategy, building on its track record of more than 150 million doses of biosimilar pharmaceuticals produced over the last two decades. Biosidus’ product portfolio comprises some of the most successful biosimilars developed to date with a focus on the treatment of chronic renal failure, cancer, multiple sclerosis, growth hormone deficiency and osteoporosis, among others. The transaction builds on ACON’s experience as one of the longest continuous investors in Latin America, having managed over $1.6 billion in investments throughout the region over the last two decades, as well as HCP’s proven experience, networks and reputation in Argentina.


Founded in 1996, ACON is a Washington, DC-based international private equity investment firm that manages private equity funds and special purpose partnerships that make investments in the United States and Latin America. ACON and its principals have managed approximately $5.3 billion of capital.

Founded in 2010, HCP is a middle-market private equity investment firm based in Buenos Aires. HCP invests primarily in family-owned companies across multiple sectors in Argentina, Chile and Uruguay, often as the local partner of choice for leading international investment firms without a dedicated presence in those countries.

Beccar Varela advised ACON Bios Investors LP and Humus Capital Partners LLC with Tomás Allende (Picture) Santiago Montezanti, Pedro Silvestri, Ana Andrés, Lucía Guardone, Juan Francisco Oria and Elizabeth Haag.

M. & M. Bomchil advised Biosidus S.A. with Fermín Caride and Máximo J. Bomchil.

Rosso Alba, Francia & Asociados advised Biosidus S.A. with Cristian Rosso Alba.

Involved fees earner: Cristian Rosso Alba – Rosso Alba, Francia & Asociados; Fermín Caride – M. & M. Bomchil; Máximo Bomchil – M. & M. Bomchil; Tomas Allende – Estudio Beccar Varela; Pedro Silvestri – Estudio Beccar Varela; Ana Andrés – Estudio Beccar Varela; Lucía Guardone – Estudio Beccar Varela; Santiago Montezanti – Estudio Beccar Varela;

Law Firms: Rosso Alba, Francia & Asociados; M. & M. Bomchil; Estudio Beccar Varela;

Clients: ACON Investments, L.L.C.; Humus Capital Partners LLC; Biosidus S.A.;

Avatar

Author: Ambrogio Visconti.